Improving COVID vaccine acceptance in African American communities
Community-Centered Interventions for Improved Vaccine Uptake for COVID (CIVIC)
This study is all about helping African American communities in Michigan get more people vaccinated against COVID-19 by working closely with local leaders and health workers to share trustworthy information and address any concerns.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Michigan at Ann Arbor NIH-funded |
| Lab location | 1 site (Ann Arbor, United States) |
| Project ID | NIH-11011434 on NIH RePORTER |
What this research studies
This research focuses on addressing the significant disparities in COVID-19 vaccine uptake among African American communities in Michigan. It employs community-centered interventions, engaging local leaders and health workers to build trust and provide accurate information about the vaccine. By understanding the unique challenges and concerns within these communities, the project aims to increase vaccination rates and reduce the impact of COVID-19. The approach includes participatory research methods that involve community members in the planning and implementation of interventions.
Who could benefit from this research
Good fit: Ideal candidates for this research are African American individuals living in Michigan, particularly those in areas with low vaccination rates.
Not a fit: Patients who are not part of the African American community or those who are already vaccinated may not receive benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to increased COVID-19 vaccination rates among African Americans, ultimately reducing illness and death in these communities.
How similar studies have performed: Other community-centered interventions have shown success in improving health outcomes in underserved populations, indicating that this approach has potential for effectiveness.
Where this research is happening
Ann Arbor, United States
- University of Michigan at Ann Arbor — Ann Arbor, United States (Active)
Researchers
- Principal investigator: Marsh, Erica E — University of Michigan at Ann Arbor
- Study coordinator: Marsh, Erica E
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.